Dachuang Cao

7PUBLICATIONS
36CO-AUTHORS
PharmacogenomicsSocial and personality psychology not elsewhere classifiedExercise physiologyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 19, 2026
Reversion to normoglycemia with tirzepatide vs semaglutide in participants with obesity and prediabetes: a post hoc analysis of SURMOUNT-5.

|Jan 15, 2026
Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT.

Thomas A Wadden, Maria A Oquendo, Robert F Kushner

|Nov 04, 2025
People With Lowest Physical Functioning Scores Showed Greatest Improvement After Tirzepatide Treatment.

Xuan Li, Dachuang Cao, Helene Sapin

|Jul 27, 2025
Early-Onset Obesity and Tirzepatide Treatment: A Post Hoc Analysis of the SURMOUNT Clinical Trials.

Evgenia Gourgari, Gitanjali Srivastava, Aaron S Kelly

|Jun 13, 2025
Kidney Parameters with Tirzepatide in Obesity with or without Type 2 Diabetes.

Hiddo J L Heerspink, Allon N Friedman, Petter Bjornstad

|Feb 25, 2025
Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight.

Michelle Look, Julia P Dunn, Robert F Kushner

Pageof 2

Frequent Collaborators

3 joint publications

Chrisanthi A Karanikas

2 joint publications

Julia P Dunn

2 joint publications

Robert F Kushner

2 joint publications

Clare J Lee